What’s New + In The News
Americans Need Generic Drugs. But Can They Trust Them?
The fake quality-control data, bird infestations and toxic impurities [...]
CVS finalizes program that mandates third party testing for all supplements
CVS Pharmacy has finalized a requirement that all supplements [...]
NJ Labs 2019 Company Christmas Secret Santa Lunch
The NJ Labs team at today's 2019 Company Christmas [...]
- 2019/3 GaBI Journal Table of Contents
- An evolving role for non-governmental organizations dealing with registration backlogs and rising costs: the example of cancer biosimilars in South Africa
- Latest features in GaBI Journal, 2019, Issue 3
- It is time to change U.S. trade policy to foster access to medicines
- Why ‘similar’ can make a big difference
- Carlos Santana Partners with Left Coast Ventures to Launch Cannabis and Hemp CBD Brands
- Purpose Investments Inc. Launches Europe’s First Cannabis ETF in Partnership with HANetf
- Global Cannabis Sales Grow 48% to $15 Billion in 2019
- CBG Biotech Introduces CannaTrue EPD Cold Ethanol Extraction System for Cannabis and Hemp
- New Mexico Governor Adds Adult-Use Cannabis Legalization to 2020 Legislative Agenda
